Literature DB >> 7437652

Comparison of the binding characteristics of tritiated opiates and opioid peptides.

M G Gillan, H W Kosterlitz, S J Paterson.   

Abstract

1 Binding assays on homogenates of guinea-pig brain showed that the maximal number of binding sites was different tritiated ligands interacting with the opiate receptors. 2 At 25 degrees C the binding capacity of morphine or dihydromorphine was only about 3 pmol/g fresh brain whereas etorphine and D-Ala2-L-Leu5- and D-Ala2-L-Met5-enkephalin amide had capacities of 13 to 15 pmol/g brain. D-Ala2-D-Leu5-enkephalin had an intermediate capacity of about 6 pmol/g brain. 3 The binding capacities of the natural methionine- and leucine-enkephalins measured at 0 degrees C were 5 to 6 pmol/g brain. At this temperature, the binding capacity of dihydromorphine, D-Ala2-D-Leu5-enkephalin and of the two enkephalin amides was only slightly lower than at 25 degrees C. 4 In assays in which unlabelled ligand competed with the same labelled ligand, the inhibition constants (KI) were equal to or not more than twice as large as the equilibrium dissociation constant (KD) determined in saturation assays. In contrast, the KI of unlabelled dihydromorphine against [3H]-D-Ala2-D-Leu5-enkephalin or of unlabelled D-Ala2-D-Leu5-enkephalin against [3H]-dihydromorphine was about 20 times higher than the respective KD values. 5 When for a given compound the ratio of the KI value against [3H]-D-Ala2-D-Leu5-enkephalin to the KI value against [3H]-dihydromorphine (discrimination ratio) is calculated, a high value indicates selectivity in favour of the mu-receptor and a low value selectivity in favour of the delta-receptor. The most selective mu-agonist known so far is normorphine with a discrimination ratio of 70 and the most selective delta-agonist is D-Ala2-D-Leu5-enkephalin with a ratio of 0.11. The selectivity of the known antagonists is in favour of the mu-receptor, since their discrimination ratios are larger than 1, varying between 10 for naloxone and 4 for Mr 2266.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437652      PMCID: PMC2044355          DOI: 10.1111/j.1476-5381.1980.tb08727.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Identification of novel high affinity opiate receptor binding in rat brain.

Authors:  G W Pasternak; S H Snyder
Journal:  Nature       Date:  1975-02-13       Impact factor: 49.962

2.  Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect.

Authors:  E J Simon; J M Hiller; J Groth; I Edelman
Journal:  J Pharmacol Exp Ther       Date:  1975-03       Impact factor: 4.030

3.  Binding of Leu5-enkephalin and Met5-enkephalin to a particulate fraction from rat cerebrum.

Authors:  J C Meunier; C Moisand
Journal:  FEBS Lett       Date:  1977-05-15       Impact factor: 4.124

4.  The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog.

Authors:  P E Gilbert; W R Martin
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

5.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

6.  Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey.

Authors:  M Hutchinson; H W Kosterlitz; F M Leslie; A A Waterfield
Journal:  Br J Pharmacol       Date:  1975-12       Impact factor: 8.739

7.  Stereospecific interaction of opiate narcotics in binding of 3H-dihydromorphine to membranes of rat brain.

Authors:  D T Wong; J S Horng
Journal:  Life Sci       Date:  1973-12-01       Impact factor: 5.037

8.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

9.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

10.  Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate.

Authors:  E J Simon; J M Hiller; I Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

View more
  30 in total

1.  Evidence for analgesia mediated by peripheral opioid receptors in inflamed synovial tissue.

Authors:  A J Lawrence; G P Joshi; A Michalkiewicz; W P Blunnie; D C Moriarty
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.

Authors:  A Schotte; P F Janssen; W Gommeren; W H Luyten; P Van Gompel; A S Lesage; K De Loore; J E Leysen
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

3.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

4.  Reconstitution of high-affinity opioid agonist binding in brain membranes.

Authors:  A E Remmers; F Medzihradsky
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

5.  The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties.

Authors:  J Magnan; S J Paterson; A Tavani; H W Kosterlitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-06       Impact factor: 3.000

6.  Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids.

Authors:  D Ramme; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

7.  Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat.

Authors:  L Negri; G F Erspamer; C Severini; R L Potenza; P Melchiorri; V Erspamer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

8.  Spectrum of the mu, delta- and kappa-binding sites in homogenates of rat brain.

Authors:  M G Gillan; H W Kosterlitz
Journal:  Br J Pharmacol       Date:  1982-11       Impact factor: 8.739

9.  Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbens.

Authors:  Pedro Rada; Jessica R Barson; Sarah F Leibowitz; Bartley G Hoebel
Journal:  Brain Res       Date:  2009-11-27       Impact factor: 3.252

10.  Evidence for the presence of a non-catecholamine, clonidine-displacing substance in crude, methanolic extracts of bovine brain and lung.

Authors:  G Singh; J F Hussain; A MacKinnon; C M Brown; D A Kendall; V G Wilson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.